Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Levcran
- Development stage
- Unknown
- Lead developer
- Alico Pharmaceutical
- Administration
- Oral
01
Overview
Levcran is a dietary supplement developed and marketed by Alico Pharmaceutical. It is identified in the company's product catalog as a "Cran Berry" product, intended for consumer retail as a nutraceutical. Unlike clinical-stage pharmaceutical candidates, Levcran does not have associated clinical trial phases or specific molecular targets defined in the provided company literature. Cranberry-based supplements are typically utilized for the maintenance of urinary tract health, primarily through the action of proanthocyanidins which may inhibit the adhesion of pathogenic bacteria to the bladder wall.
- Brand names
- Levcran
- Other names
- Cran Berry
Beyond the preview
Go deeper on Levcran.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Levcran.